Skip to the main content
The Crier

PHE_Scientific - Direct award for purchase of RTPCR - Quantstudio 5 for Newborn Blood Spot Screening Evaluation for SCID

Your saved contracts

What the buyer wrote

Public Health England has awarded a contract to Life Technologies Ltd for provision of purchase of RTPCR - Quantstudio 5 instruments. under Lot 1 of PHE Microbiology Framework via Direct-award for evaluation study of New Born Blood Spot Screening Programme (NBS).

Bid for this and lost? There is a short window in which the decision can be questioned.

Awarded to

Life Technologies Limited£405kends (31 Aug 2023)

Details

What the buyer calls it
PHE_Scientific - Direct award for purchase of RTPCR - Quantstudio 5 for Newborn Blood Spot Screening Evaluation for SCID
How they are buying
Called off an existing agreementThe work went to a supplier already on a framework or dynamic market.
Type
goods
Suitable for small firms
The buyer says yes. What that is worth
Work starts
19 Feb 2020
Work ends
31 Aug 2023

Who the buyer named

The buyer published a contact address on this notice.

jeff.pike@phe.gov.uk